VAERS reports by lot

GSK Varicella/Shingles lot 9AB33: VAERS reports

28 VAERS reports list lot 9AB33 as a GSK Varicella/Shingles vaccine, received between 2019-09-15 and 2021-02-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2322%
General / Systemic (non-local)2120%
Dermatological (non-injection-site)2019%
Musculoskeletal1312%
Gastrointestinal88%
Neurological77%
Thrombotic / Hematological33%
Allergic / Anaphylactic33%
Cardiac / Cardiovascular22%
Psychiatric / Neuropsychiatric22%
Autoimmune / Immune-mediated11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania3
Ohio3
New Jersey3
New York2
Idaho2
Arizona2
Utah2
Alabama1
Massachusetts1
South Carolina1
Oklahoma1
Maryland1

Reports by month received

2019-096
2019-1010
2019-113
2019-122
2020-013
2020-082
2020-101
2021-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.